EquityZen Growth Technology Fund LLC - Series 327
Raised
$1M
Investors
34
Min Invest
$19,580
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 327 is a Delaware pooled investment fund vehicle filed by EquityZen Advisors LLC on 2018-10-03. The fund raised $1.2M from 34 investors with a $20K minimum investment, claiming exemptions under Rule 506(b) and Section 3(c)(1). This is part of EquityZen's platform of over 1,800 related entities providing access to pre-IPO technology company shares.
This pre-IPO fund operates under the standard 506(b) / 3(c)(1) exemption structure common to private placement vehicles targeting accredited investors. The $20K minimum positions it at the lower end of institutional alternative investments, consistent with EquityZen's retail-accessible model for secondary market exposure to private growth companies.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Richard Thoms
Executive Officer · Salt Lake City, UT
Assure Fund Management II LLC
Director · Salt Lake City, UT
Shriram Bhashyam
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.
